Market Overview:
The global therapeutic peptide market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for novel therapeutics, and technological advancements in peptide synthesis. The global therapeutic peptide market is segmented by type, application, and region. By type, the market is divided into oral therapeutic peptides, injection therapeutic peptides, and other types of therapeutic peptides. The injection therapy segment is expected to grow at a higher CAGR during the forecast period owing to its advantages such as high efficacy and long half-life. By application, the market is classified into cancer therapeutics, metabolic disorders therapeutics Central Nervous System (CNS) therapies), and other applications such as cardiovascular diseases (CVDs), ophthalmology & optometry etc.). Cancer therapeutics held a dominant share in 2017 owing to increase in incidence rates of various cancers across the globe coupled with rising demand for better treatment options.
Product Definition:
Therapeutic Peptide is a peptide molecule that has been specifically designed to treat or prevent disease. Therapeutic peptides can be used to activate the immune system, kill cancer cells, or reduce inflammation.
Oral:
Oral peptides are small proteins that are naturally produced by the body and some drugs. They have various therapeutic benefits which include anti-inflammatory, analgesic (pain relief), vasopressin receptor antagonists (antidiuretic hormone), insulin, growth factor and antimicrobial peptides. The most commonly used oral peptide is insulin as it helps in regulating blood sugar levels in patients suffering from diabetes mellitus.
Injection:
Injection is a process through which the peptide hormone is administered into the patient's body. Peptides are small chains of amino acids, and their hormones are used to treat various diseases such as diabetes, arthritis, etc.
Application Insights:
The cancer segment dominated the global therapeutic peptide market in 2017 and is expected to witness significant growth during the forecast period. The growing prevalence of cancer and increasing awareness about its treatment are some of the key factors driving this segment. For instance, according to data published by WHO in 2018, around 1 in 6 women and 1 in 5 men are estimated to develop cancer during their lifetime. Moreover, as per estimates from 2016-2017 Global Cancer Research Report prepared by American Institute for Cancer Research (AICR), it is estimated that around 4 million people developed cancer that year globally with an average of 940 new cases every day across the globe. These statistics indicate a huge unmet clinical need and high potential market opportunity for novel therapeutics development against cancers.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players and high adoption rate for new technologies. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by companies as well as government agencies. For instance, every year Novartis Corporation makes significant donations for research purposes at universities in Switzerland. These factors are anticipated to boost revenue growth in this region during the forecast period.
Asia Pacific therapeutic peptide market is expected witness lucrative growth during the forecast period owing to rising healthcare expenditure levels coupled with growing awareness regarding advanced therapies among patients suffering from chronic disorders such as cancer, diabetes, & cardiovascular diseases (CVDs). Moreover, an increase in prevalence of neurological disorders such as Alzheimer’s disease (AD) has led researchers and pharmaceutical companies focus on developing novel therapeutics that can help improve cognitive functioning among patients suffering from AD or Parkinson's disease (PD).
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is expected to drive the demand for therapeutic peptides over the forecast period.
- Growing awareness about the benefits of therapeutic peptides is anticipated to boost their demand in the near future.
- Rising number of research and development activities for novel therapeutics is projected to propel the growth of this market in forthcoming years.
- Technological advancements in peptide synthesis are likely to create new opportunities for this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Therapeutic Peptide Market Research Report
By Type
Oral, Injection, Other
By Application
Cancer, Metabolic Disorders, Central Nervous System, Other
By Companies
AbbVie, AstraZeneca, Ipsen, Eli Lilly, Merck, Novo Nordisk, Novartis, Johnson and Johnson, Sanofi, Teva, Takeda
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Therapeutic Peptide Market Report Segments:
The global Therapeutic Peptide market is segmented on the basis of:
Types
Oral, Injection, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Metabolic Disorders, Central Nervous System, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- AstraZeneca
- Ipsen
- Eli Lilly
- Merck
- Novo Nordisk
- Novartis
- Johnson and Johnson
- Sanofi
- Teva
- Takeda
Highlights of The Therapeutic Peptide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- Other
- By Application:
- Cancer
- Metabolic Disorders
- Central Nervous System
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Therapeutic Peptide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Therapeutic peptides are short, linear proteins that are isolated from natural sources or synthesized in the laboratory. They have been shown to have a variety of therapeutic properties, including anti-inflammatory and analgesic effects.
Some of the key players operating in the therapeutic peptide market are AbbVie, AstraZeneca, Ipsen, Eli Lilly, Merck, Novo Nordisk, Novartis, Johnson and Johnson, Sanofi, Teva, Takeda.
The therapeutic peptide market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Therapeutic Peptide Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Therapeutic Peptide Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Therapeutic Peptide Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Therapeutic Peptide Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Therapeutic Peptide Market Size & Forecast, 2020-2028 4.5.1 Therapeutic Peptide Market Size and Y-o-Y Growth 4.5.2 Therapeutic Peptide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Metabolic Disorders
6.2.3 Central Nervous System
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Therapeutic Peptide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Therapeutic Peptide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Metabolic Disorders
9.10.3 Central Nervous System
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Metabolic Disorders
10.10.3 Central Nervous System
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Metabolic Disorders
11.10.3 Central Nervous System
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Metabolic Disorders
12.10.3 Central Nervous System
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Metabolic Disorders
13.10.3 Central Nervous System
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Therapeutic Peptide Market: Competitive Dashboard
14.2 Global Therapeutic Peptide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 AstraZeneca
14.3.3 Ipsen
14.3.4 Eli Lilly
14.3.5 Merck
14.3.6 Novo Nordisk
14.3.7 Novartis
14.3.8 Johnson and Johnson
14.3.9 Sanofi
14.3.10 Teva
14.3.11 Takeda